Hologic gets CE Mark for breast specimen x-ray system

By LabPulse.com staff writers

November 12, 2020 -- Hologic has received the CE Mark for its Faxitron Path+ specimen radiography system, which can be used for breast tissue imaging. The system consists of a high-resolution detector that allows pathologists to image specimens of various sizes.

Faxitron Path+ offers up to 10 times geometric magnification, which helps image small microcalcifications; users can choose the best x-ray exposure settings for particular specimens.

Hologic acquired digital specimen radiography company Faxitron Bioptics, the maker of the system, in 2018.

Hologic Q4 sales boom on diagnostics revenues
Booming revenues in its Molecular Diagnostics segment due to the COVID-19 pandemic helped Hologic post a 55.6% increase in sales for its fourth quarter....
Hologic scores $119M COVID-19 testing contract
The U.S. government has awarded a $119 million contract to Hologic to expand its production capacity for COVID-19 molecular tests.
Hologic debuts pooling protocol for COVID-19 tests
Hologic has validated the use of its Aptima and Panther Fusion molecular diagnostic COVID-19 assays with pooled patient samples and has also applied for...
FDA gives Hologic EUA for SARS-CoV-2 test
The U.S. Food and Drug Administration (FDA) gave Hologic emergency use authorization (EUA) for its Aptima SARS-CoV-2 molecular test for detection of the...
Hologic debuts research-use-only SARS-CoV-2 test
Hologic has launched a research-use-only version of a new molecular assay that can detect SARS-CoV-2 and which is expected to dramatically increase testing...

Copyright © 2020 LabPulse.com

Last Updated ls 11/12/2020 5:04:34 PM